SciBase Holding AB (publ) SCIB.ST · SEK

Its shares trade on Nasdaq Stockholm under the ticker SCIB.ST. It has been listed since 2 June 2015. In the fiscal year to 31 December 2025, it reported revenue of SEK 40.5m and a net loss of SEK 87.1m. At that date it held total assets of SEK 52.2m and shareholders' equity of SEK 6.7m.

SciBase Holding AB is a medical technology company, which engages in the development and sale of instruments for the detection of skin cancer and other skin diseases. The company is headquartered in Sundbyberg, Stockholm. The company went IPO on 2015-06-02. The firm specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. The diagnostic product is sold in Nordic countries, Belgium, Germany, Great Britain and Australia.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Jesper HoilandNon-Executive Independent Chairman of the BoardSEK 219,000
• Ms. Pia RenaudinChief Executive OfficerSEK 3.2m
• Mr. Michael ColerusChief Financial OfficerSEK 272,535
• Ms. Angelica KorsfeldtDirector of Product Development
• Mr. Alf LaurellDirector of Quality Assurance and Regulatory Affairs
• Ms. Linn OlsenSupply Chain and Production Manager
• Mr. Per SvedenhagHead of Business Development and MarketingSEK 1.4m
• Ms. Anna EriksrudIndependent Director
• Ms. Diana FerroIndependent DirectorSEK 223,000
• Mr. Robert MolanderIndependent DirectorSEK 73,000

Overall

30

Environment

15

Social

39

Governance

35

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.